Uveitis

September 24, 2026

Hidden eyelash mimics uveitis

Ultrasound biomicroscopy detected a foreign body concealed in the angle recess after inflammation subsided.

MDSpire News

September 23, 2026

FDA Accepts Vamikibart BLA for Uveitic Macular Edema

New phase 3 data presented at AAO 2026 showed sustained visual and anatomic improvements through 52 weeks in the MEERKAT and SANDCAT trials.

Retinal Physician

September 01, 2026

JIA-Associated Uveitis in Adults

Ophthalmologists caring for adults with this condition may encounter persistent inflammation, treatment dependence, and the cumulative ocular effects of childhood disease.

Retinal Physician

September 01, 2026

Evolving Treatment Strategies for Noninfectious Uveitis

Advances in corticosteroid delivery, systemic immunomodulation, and pipeline therapies are expanding options for individualized management.

Retinal Physician

September 01, 2026

Optimizing Corticosteroid Therapy in Uveitis

Multiple corticosteroid approaches are available for the management of noninfectious uveitis, including injectable triamcinolone, sustained-release dexamethasone implants, and fluocinolone implants. The optimal choice depends on disease location, desired duration of effect, treatment burden, lens status, and tolerance for potential adverse effects such as cataract progression and elevated intraocular pressure (IOP).

Retinal Physician